Search for Clinical Trial Results

Sponsored By

Hyperlipoproteinemia Type V - 13 Studies Found

Status Study
Terminated Study Name: MK0859 Dose-Ranging Study (0859-003)
Condition:
  • Hypercholesterolemia
  • Mixed Hyperlipemia

Date: 2006-05-11
Interventions: Drug: MK0859
Completed Study Name: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Condition:
  • Hypertriglyceridemia
  • Hyperlipoproteinemia Type IV
  • Date: 2007-05-14
    Interventions: Drug: rosuvastatin 10mg or 20mg
Withdrawn Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction
Condition: Mixed Hyperlipoproteinemia
Date: 2014-02-20
Interventions:
  • Dietary Supplement: Pro-Omega LDL
  • Other: P
Withdrawn Study Name: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Date: 2013-10-25
Interventions:
  • Drug: Atorvastatin 10mg, fenofibric acid 135mg

Completed Study Name: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
Condition: Mixed Hyperlipidemia
Date: 2006-02-07
Interventions:
  • Drug: MK-0524A
  • Drug: Atorvastatin

Terminated Study Name: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Condition: Mixed Hyperlipidemia
Date: 2005-08-22
Interventions:
  • Drug: torcetrapib/atorvastatin
  • Drug: atorv
Completed Study Name: A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Condition:
  • Hypertriglyceridemia
  • Mixed Hyperlipidemia

Date: 2013-12-06
Interventions:
  • Drug: TRIA-662 Following Basel
Completed Study Name: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
Condition:
  • Primary Hypercholesterolemia
  • Mixed Hyperlipidemia

Date: 2009-07-16
Interventions:
  • Drug: SCH 900271 15mg oral tab
Completed Study Name: Lipid Efficacy Study (0524B-022)(COMPLETED)
Condition:
  • Primary Hypercholesterolemia
  • Mixed Hyperlipidemia

Date: 2005-12-21
Interventions:
  • Drug: niacin (+) laropiprant (+) simvastatin

Completed Study Name: Lipid Efficacy/Tolerability Study (0524A-020)
Condition:
  • Primary Hypercholesterolaemia
  • Mixed Hyperlipidaemia

Date: 2005-12-21
Interventions:
  • Drug: niacin (+) laropiprant D
Next >>>